Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 7 results

Drug Interactions Between Common Dermatological Medications and the Oral Anti-Covid-19 Agents Nirmatrelvir-Ritonavir and Molnupiravir

research Drug Interactions Between Common Dermatological Medications and the Oral Anti-Covid-19 Agents Nirmatrelvir-Ritonavir and Molnupiravir

5 citations , December 2022 in “Annals Academy of Medicine Singapore”

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

research The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19

6 citations , March 2022 in “Frontiers in drug discovery”

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Drug Repositioning Approach to Target Viral and Host Cells for COVID-19 Treatment: A Review of In Vivo Experiments and Clinical Studies

research Drug Repositioning Approach to Target Viral and Host Cells for COVID-19 Treatment: A Review of In Vivo Experiments and Clinical Studies

October 2022 in “Journal of experimental and clinical medicine”

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

research An Update on Antiviral Treatment of COVID-19

51 citations , August 2021 in “Turkish Journal of Medical Sciences”

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

research Therapeutics for COVID-19 and Post COVID-19 Complications: An Update

52 citations , January 2022 in “Current Research in Pharmacology and Drug Discovery”

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

View more "molnupiravir" in research →

Community Join

0 / 0 results

— no results